期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 11, 页码 3453-3456出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm9004303
关键词
-
The optimization of a potent, class I selective ketone HDAC inhibitor is shown. It possesses optimized pharmacokinetic properties in preclinical species, has a clean off-target profile, and is negative in a microbial mutagenicity (Ames) test. In a mouse xenograft model it shows efficacy comparable to that of vorinostat at a 10-fold reduced dose.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据